BioWorld-Insight-2003-04-07
Stock Winners and Losers For The Week
Regeneron's Axokine Story Continues; Subset Holds Hope
"It's all Axokine," said analyst Steven Harr with Morgan Stanley in New York, earlier this month.
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Thompson.com | Sheshunoff.com | ASPratt.com | AHCMedia.com | BioWorld.com | CMEweb.com | ThePerformanceInstitute.org | ASMIweb.com
Editorial Guidelines
For Site License Discounts, please contact Customer Service at (800) 477-6307 or customerservice@bioworld.com.